The stock had dipped from its debut price ahead
of Thursday closing, with analysts saying the lower price should
be viewed as more reasonable and based on the fundamentals of a
company which relies heavily on that one boy band for revenue.
Analysts said Big Hit's valuation based on its initial public
offering (IPO) price of 135,000 won per share was comparable to
peers such as K-Pop agencies SM Entertainment Co Ltd <041510.KQ>
and JYP Entertainment Corp <035900.KQ>.
They said the price, which fell as low as 199,000 won on Friday,
seemed to be returning to Earth after a period of overheated
speculation pushed Big Hit's debut to double the IPO price and
then fuelled a further 30% surge shortly after.
The short-lived surge echoed the strong debuts of SK
Biopharmaceuticals Co Ltd <326030.KS> in July and Kakao Games
Corp <293490.KQ> last month, as South Korean retail investors
known as "Ants" capitalise on government economic stimulus which
has flooded markets with cash.
However, unlike a pharmaceutical maker with a pipeline of drugs
or a mobile game developer benefiting from a stay-at-home trend,
K-pop agencies that depend on a few star artists can see more
fluctuation in share prices, analysts said.
BTS accounted for 97.4% of Big Hit's revenue in 2019 and 87.7%
in the first half of 2020, a regulatory filing showed.
"Big Hit's reliance on BTS is still absolute when including
non-management, indirect sales such as merchandise, intellectual
property and content," said Hyundai Motor Securities analyst Kim
Hyun-yong. "It must make all-out efforts to create a post-BTS
revenue source."
The KOSPI benchmark <.KS11> closed down 0.8%.
(Reporting by Joyce Lee; Editing by Christopher Cushing)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|